Use sympatholytic agents management hypertension Considerable evidence hyperactivity sympathetic nervous system pathogenesis essential hypertension several blood pressure-independent complications essential hypertension advent antihypertensive agents angiotensin-converting enzyme inhibitors calcium antagonists sympatholytics alpha agonists valuable group medications management hypertension grades severity advantages efficacy rarity contraindication absence metabolic serious side effects favorable effects systemic hemodynamics lack true tolerance infrequency volume expansion-related pseudotolerance suitability elderly isolated systolic hypertension patients various concomitant conditions diabetes ability left ventricular hypertrophy low cost long duration action guanfacine hydrochloride agent transdermal formulation clonidine commendable feature principal disadvantages class medications overlap therapeutic dosage sedation dry mouth potential discontinuation syndrome sexual dysfunction 